Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
detroit blog main
4
×
detroit top stories
national blog main
national top stories
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
eli lilly
fremanezumab
indiana blog main
indiana top stories
life sciences
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
calcitonin gene-related peptide
eptinezumab
erenumab
fda
galcanezumab
migraine
migraine research foundation
novartis
What
approval
4
×
new
4
×
drug
fda
class
companies
developed
migraine
won
amgen
ann
announced
arbor
arguments
based
big
bio
biogen’s
biopharmaceutical
candidates
capital
commercialized
competitors
convo
decades
drugs
earlier
eye
failures
fifth
gets
head
littered
make
medical
medicines
meeting
michigan
nash
neuro
Language
Current search:
new
×
" detroit blog main "
×
" national top stories "
×
approval
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines